1. Gattinoni, L, Coppola, S, Cressoni, M, et al. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299-1300. doi:10.1164/rccm.202003-0817LE.
Google Scholar | Crossref | Medline2. Chang, R, Elhusseiny, KM, Yeh, Y-C, et al. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis. PLoS ONE. 2021;16(2):e0246318. doi:10.1371/journal.pone.0246318.
Google Scholar | Crossref | Medline3. Demoule, A, Baron, AV, Darmon, M, et al. High-flow nasal cannula in critically III patients with severe COVID-19. Am J Respir Crit Care Med. 2020;202(7):1039-1042. doi:10.1164/rccm.202005-2007LE.
Google Scholar | Crossref | Medline4. Nishimura, M . High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529. doi:10.4187/respcare.04577.
Google Scholar | Crossref | Medline5. Chandel, A, Patolia, S, Brown, AW, et al. High-flow nasal cannula in COVID-19: outcomes of application and examination of the ROX index to predict success. Respir Care. 2020. doi:10.4187/respcare.08631.
Google Scholar | Medline6. Saunders, JL, Davis, MD. 2020 Year in review: pharmacologic treatments for COVID-19. Respir Care. 2021;66(7):1167. doi:10.4187/respcare.09153.
Google Scholar | Crossref | Medline7. Dellinger, RP, Zimmerman, JL, Taylor, RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group. Crit Care Med. 1998;26(1):15-23. doi:10.1097/00003246-199801000-00011.
Google Scholar | Crossref | Medline8. Griffiths, MJ, Evans, TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005;353(25):2683-2695. doi:10.1056/NEJMra051884.
Google Scholar | Crossref | Medline9. Adhikari, NK, Dellinger, RP, Lundin, S, et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med. 2014;42(2):404-412. doi:10.1097/CCM.0b013e3182a27909.
Google Scholar | Crossref | Medline10. Gebistorf, F, Karam, O, Wetterslev, J, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016(6):CD002787. doi:10.1002/14651858.CD002787.pub3.
Google Scholar | Medline11. Davis, SL, Crow, JR, Fan, JR, et al. Use and costs of inhaled nitric oxide and inhaled epoprostenol in adult critically ill patients: a quality improvement project. Am J Health Syst Pharm. 2019;76(18):1413-1419. doi:10.1093/ajhp/zxz151.
Google Scholar | Crossref | Medline12. Tzanetos DR, T, Housley, JJ, Barr, FE, et al. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015;60(5):644. doi:10.4187/respcare.03308.
Google Scholar | Crossref | Medline13. Akerstrom, S, Mousavi-Jazi, M, Klingstrom, J, et al. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005;79(3):1966-1969. doi:10.1128/JVI.79.3.1966-1969.2005.
Google Scholar | Crossref | Medline14. Fang, W, Jiang, J, Su, L, et al. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med. 2021;163:153-162. doi:10.1016/j.freeradbiomed.2020.12.008.
Google Scholar | Crossref | Medline15. Bagate, F, Tuffet, S, Masi, P, et al. Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome. Ann Intensive Care. 2020;10(2020):151. doi:10.1186/s13613-020-00769-2.
Google Scholar | Crossref | Medline16. Longobardo, A, Montanari, C, Shulman, R, et al. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome. Br J Anaesth. 2021;126(1):e44-e46. doi:10.1016/j.bja.2020.10.011.
Google Scholar | Crossref | Medline17. Ferrari, M, Santini, A, Protti, A, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159-160. doi:10.1016/j.jcrc.2020.08.007.
Google Scholar | Crossref | Medline18. Parikh, R, Wilson, C, Weinberg, J, et al. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients. Ther Adv Respir Dis. 2020;14(1):1753466620933510. doi:10.1177/1753466620933510.
Google Scholar | SAGE Journals19. Tavazzi, G, Pozzi, M, Mongodi, S, et al. Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia. Crit Care 2020;24(2020):508. doi:10.1186/s13054-020-03222-9.
Google Scholar | Crossref | Medline20. Abou-Arab, O, Huette, P, Debouvries, F, et al. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study. Crit Care 2020;24(2020):645. doi:10.1186/s13054-020-03371-x.
Google Scholar | Crossref | Medline21. Wiegand, SB, Safaee Fakhr, B, Carroll, RW, et al. Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019. Crit Care Explor. 2020;2(11):e0277. doi:10.1097/cce.0000000000000277.
Google Scholar | Crossref | Medline22. Bellerophon Therapeutics . Bellerophon Therapeutics Announces Results of Interim Analysis of Phase 3 COViNOX Study of INOpulse® for the Treatment of COVID-19. 2020.
Google Scholar23. Ely, EW, Truman, B, Shintani, A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003;289(22):2983-2991. doi:10.1001/jama.289.22.2983.
Google Scholar | Crossref | Medline24. Berger, JS, Kunichoff, D, Adhikari, S, et al. Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;40(10):2539-2547. doi:10.1161/ATVBAHA.120.314872.
Google Scholar | Crossref | Medline25. Kline, JA, Puskarich, MA, Jones, AE, et al. Inhaled nitric oxide to treat intermediate risk pulmonary embolism: a multicenter randomized controlled trial. Nitric Oxide 2019;84:60-68. doi:10.1016/j.niox.2019.01.006.
Google Scholar | Crossref | Medline26. Lang, M, Som, A, Mendoza, DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis. 2020;20(12):1365-1366. doi:10.1016/s1473-3099(20)30367-4.
Google Scholar | Crossref | Medline27. Reynolds, AS, Lee, AG, Renz, J, et al. Pulmonary vascular dilatation detected by automated transcranial Doppler in COVID-19 pneumonia. Am J Respir Crit Care Med. 2020;202(7):1037-1039. doi:10.1164/rccm.202006-2219LE.
Google Scholar | Crossref | Medline